Business Description
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.78 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | 2.36 | |||||
Interest Coverage | 0.86 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 12.07 | |||||
Beneish M-Score | 1.73 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.9 | |||||
3-Year EBITDA Growth Rate | -2.3 | |||||
3-Year EPS without NRI Growth Rate | -42.5 | |||||
3-Year FCF Growth Rate | -6.5 | |||||
3-Year Book Growth Rate | 37.4 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.19 | |||||
9-Day RSI | 42.19 | |||||
14-Day RSI | 47.92 | |||||
6-1 Month Momentum % | 43.52 | |||||
12-1 Month Momentum % | -3.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.03 | |||||
Quick Ratio | 2.02 | |||||
Cash Ratio | 0.71 | |||||
Days Inventory | 164.03 | |||||
Days Sales Outstanding | 91.15 | |||||
Days Payable | 49.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -0.68 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 19.78 | |||||
Operating Margin % | 1.39 | |||||
Net Margin % | 2.99 | |||||
FCF Margin % | -10.66 | |||||
ROE % | 1.71 | |||||
ROA % | 1.46 | |||||
ROIC % | 0.61 | |||||
ROC (Joel Greenblatt) % | 9.65 | |||||
ROCE % | 3.04 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 191.76 | |||||
PE Ratio without NRI | 141.74 | |||||
Shiller PE Ratio | 33.92 | |||||
PS Ratio | 6.49 | |||||
PB Ratio | 2.76 | |||||
Price-to-Tangible-Book | 2.76 | |||||
EV-to-EBIT | 114.65 | |||||
EV-to-EBITDA | 87.55 | |||||
EV-to-Revenue | 6.54 | |||||
EV-to-FCF | -63.51 | |||||
Price-to-Projected-FCF | 9.06 | |||||
Price-to-Graham-Number | 4.18 | |||||
Price-to-Net-Current-Asset-Value | 15.52 | |||||
Earnings Yield (Greenblatt) % | 0.87 | |||||
FCF Yield % | -1.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genpharmasec Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 278.111 | ||
EPS (TTM) (₹) | 0.017 | ||
Beta | -0.38 | ||
Volatility % | 119.78 | ||
14-Day RSI | 47.92 | ||
14-Day ATR (₹) | 0.26491 | ||
20-Day SMA (₹) | 3.3805 | ||
12-1 Month Momentum % | -3.09 | ||
52-Week Range (₹) | 1.92 - 7.31 | ||
Shares Outstanding (Mil) | 553.72 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genpharmasec Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genpharmasec Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Genpharmasec Ltd Frequently Asked Questions
What is Genpharmasec Ltd(BOM:531592)'s stock price today?
When is next earnings date of Genpharmasec Ltd(BOM:531592)?
Does Genpharmasec Ltd(BOM:531592) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |